BIAF
bioAffinity Technologies, Inc.
NASDAQ: BIAF · HEALTHCARE · DIAGNOSTICS & RESEARCH
$2.49
+2.26% today
Updated 2026-04-30
Market cap
$10.03M
P/E ratio
—
P/S ratio
1.63x
EPS (TTM)
$-8.66
Dividend yield
—
52W range
$1 – $15
Volume
10.8M
bioAffinity Technologies, Inc. (BIAF) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
0 of 8
Last 8 quarters
Avg EPS surprise
-94.0%
Last 4 quarters
Revenue YoY growth
-27.8%
Most recent quarter
EPS YoY growth
-267.1%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+32.8%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+78.5%
2026-03-13
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-13 | $-0.70 | — | $1.07 | $1.91 | +78.5% |
| 2025-11-12 | $-4.74 | -4931.8% | $2.16 | $1.88 | -13.0% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | — | $-0.70 | — | $1.59M | -27.8% |
| 2025-09-30 | $-0.09 | $-4.74 | -4931.8% | $1.45M | -38.5% |
| 2025-06-30 | $-0.10 | $-0.17 | -70.0% | $1.27M | -47.1% |
| 2025-03-31 | $-0.17 | $-0.19 | -12.1% | $1.85M | -23.0% |
| 2024-12-31 | $-0.14 | $-0.19 | -35.7% | $2.21M | -0.3% |
| 2024-09-30 | $-0.15 | $-0.16 | -6.7% | $2.35M | +687.4% |
| 2024-06-30 | $-0.17 | $-0.19 | -11.8% | $2.40M | +12047.4% |
| 2024-03-31 | $-0.20 | $-0.26 | -28.3% | $2.41M | +261180.2% |
| 2023-12-31 | $-0.20 | $0.00 | +100.0% | $2.21M | — |
| 2023-09-30 | $-0.15 | $-0.26 | -73.3% | $298484.00 | — |
| 2023-06-30 | $-0.20 | $-0.20 | +0.0% | $19738.00 | — |
| 2023-03-31 | $-0.18 | $-0.18 | +0.0% | $921.00 | — |
Frequently asked questions
Has bioAffinity Technologies, Inc. beaten earnings estimates?
bioAffinity Technologies, Inc. has beaten Wall Street EPS estimates in 0 of its last 8 quarterly reports, with an average EPS surprise of -94.0% over the last 3 quarters.
How does BIAF stock react to earnings?
BIAF stock has moved an average of +32.8% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is bioAffinity Technologies, Inc.'s revenue growth rate?
bioAffinity Technologies, Inc. reported year-over-year revenue growth of -27.8% in its most recent quarter, with EPS growing -267.1% year-over-year.